Episode
Aimee Raleigh (Atlas Venture): Building Biotech Companies from Day One
- Podcast
- The NextGen VC Podcast
- Published
- May 6, 2026
- Duration seconds
- 3216
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-nextgen-vc-podcast-6617779/episodes/aimee-raleigh-atlas-venture-building-biotech-companies-from-day-one/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-nextgen-vc-podcast-6617779/aimee-raleigh-atlas-venture-building-biotech-companies-from-day-one.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
What does it actually take to turn an idea into a biotech company? Aimee Raleigh, PhD, Principal at Atlas Venture, joins Mike and Jen as she walks through how companies get built before they’re even companies. From evaluating early science to forming a real point of view, Aimee shares how investors build conviction at the earliest stages. We get into the pace of early-stage venture, how to juggle multiple opportunities, make decisions with imperfect data, figure out what’s worth leaning into, and more. Aimee discusses her path into venture and what she’s learned along the way in an industry that doesn’t slow down. Listen and be prepared to walk away seeing early-stage ventures a little differently.